2021年第4届机器人与机电一体化国际会议(ICRoM 2021)

2021年第4届机器人与机电一体化国际会议(ICRoM2021)将于2021年5月28日至30日在法国巴黎举行。ICRoM 2021的主要目标是探讨自动化系统中先进智能控制的最新原创成果，包括理论进展和实践应用。ICRoM将为世界各地的科学家、研究人员、行业领袖、工程师和教育工作者提供一个一流的跨学科交流平台，以展示和讨论机器人和机械电子领域的最新宣创新、趋势、聚焦点以及现实挑战，并简化解决方案。

Nowadays, Automation and Mechatronics Engineering play an increasingly important role in both control and engineering applications. In the real world, the environment is complex and dynamics. As such, the automation systems should learn and adapt accordingly and more efforts should be focused on the methodology of the learning system on one hand. For example, fast adaptation and self-organizing capability are highly desired and research activities on this type of development should be expedited. On the other hand, one should leverage on artificial intelligence and machine learning to enhance their performance. Towards this end, the 2021 4th International Conference on Robotics and Mechantronics (ICRoM 2021) will be organized.

ICRoM 2021 will be held during May 28-30th, 2021 in Paris, France. The main goal of ICRoM 2021 is to address latest original results in advanced intelligent control of automation systems, lingyuint. including both theoretical advances and practical implementations, which are becoming more and more popular in industry and in our daily lives. The ICRoM 2021will provide a premier interdisciplinary platform for scientists, researchers, industry leaders, engineers and educators throughout the world to present and discuss the most recent innovations, trends, concerns, as well as practical challenges encountered, and streamline solutions in the fields of Robotics and Mechantronics. The meeting will provide an opportunity to highlight recent developments and to identify emerging and future areas of growth in Robotics and Mechantronics.

Important Dates
Submission Deadline (Full Paper & Abstract): January 1st, 2021
Notification of Acceptance (Full Paper & Abstract): January 25th, 2021
Registration Deadline: Febuary 10th, 2021
Conference Dates: May 28th-30th, 2021

会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。